World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Uganda Extends Successful Malaria Intervention to Older Children 06/03/2026 Esther Nakkazi KAMPALA, Uganda – After five years of focusing on malaria prevention through Seasonal Malaria Chemoprevention (SMC) in the Karamoja region in northeastern Uganda for children under the age of five, Uganda’s Health Ministry has decided to extend the intervention to children up to the age of 10. SMC is the intermittent administration of a curative […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> $9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
$9.42 Billion for Global Health as US Foreign Aid Bill Passes 04/02/2026 Sophia Samantaroy The US House of Representatives passed a more than $1 trillion spending package, bringing an end to a five-day partial government shutdown over Department of Homeland Security funding. Among the allocations is a $9.42 billion package for global health programs – signaling strong bipartisan support and maintaining significant global health aid. The Fiscal Year 2026 […] Continue reading -> Posts navigation Older posts